Ken Griffin Medicinova Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Medicinova Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 9,400 shares of MNOV stock, worth $20,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,400

Previous 7,200 30.56%

Holding current value

$20,398

Previous $10,000 90.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.13 - $2.1 $18,981 - $35,275	-16,798 Reduced 92.15%	1,431 $3,000
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.57 $10,167 - $12,470	-7,943 Reduced 30.35%	18,229 $26,000
Q1 2024 May 15, 2024	BUY	$1.28 - $1.65 $33,500 - $43,183	26,172 New	26,172 $37,000
Q2 2023 Aug 14, 2023	SELL	$2.09 - $2.43 $8,556 - $9,948	-4,094 Reduced 20.9%	15,492 $35,000
Q1 2023 May 15, 2023	SELL	$1.95 - $2.54 $42,219 - $54,993	-21,651 Reduced 52.5%	19,586 $42,000
Q4 2022 Feb 14, 2023	BUY	$1.97 - $2.66 $32,918 - $44,448	16,710 Added 68.13%	41,237 $84,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.6 $9,672 - $11,975	-4,606 Reduced 15.81%	24,527 $53,000
Q2 2022 Aug 15, 2022	BUY	$2.31 - $3.14 $67,297 - $91,477	29,133 New	29,133 $74,000
Q1 2022 May 16, 2022	SELL	$2.19 - $2.81 $52,910 - $67,889	-24,160 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.42 $28,783 - $48,743	11,028 Added 83.98%	24,160 $64,000
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $180,591 - $225,207	-53,115 Reduced 80.18%	13,132 $50,000
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $147,880 - $202,156	39,330 Added 146.12%	66,247 $281,000
Q1 2021 May 17, 2021	BUY	$4.81 - $8.74 $66,113 - $120,131	13,745 Added 104.35%	26,917 $136,000
Q3 2020 Nov 16, 2020	SELL	$4.67 - $11.0 $36,108 - $85,052	-7,732 Reduced 36.99%	13,172 $69,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $17,898 - $43,018	-6,172 Reduced 22.8%	20,904 $78,000
Q4 2019 Feb 14, 2020	SELL	$6.48 - $8.76 $52,429 - $70,877	-8,091 Reduced 23.01%	27,076 $182,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.42 $20,543 - $27,800	-2,668 Reduced 7.05%	35,167 $279,000
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $209,156 - $333,540	25,230 Added 200.16%	37,835 $364,000
Q4 2017 Feb 09, 2018	BUY	$5.89 - $7.21 $74,243 - $90,882	12,605	12,605 $82,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.83M

Call Options Held

9.4K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account